Lawyers fear Democrats' surge to the White House

Share this article:

Food and drug lawyers at a Washington media briefing in January contended that with Democrats controlling Congress and potentially taking the White House this year, drug companies' worst fears about federal and state legislation regulating drug promotion will become reality. They spoke at Washington Legal Foundation session titled Health Product Promotion: Will New Rules, Greater Disclosure Chill Education and Free Speech?

All three speakers expressed concern that too much attention and resources are being devoted to regulating drug promotion when there is little evidence that prescribers are improperly influenced by promo activities. Marc Scheineson (Alston & Bird) said the perceived high cost of drugs is responsible for much of the attack on drug promotion. “No direct connection has been found between marketing costs and drug costs,” he declared. “If drug companies voluntarily lowered drug prices, all this interest in promotion would disappear.”

Scheineson said the industry is one of the most heavily regulated industries. He said evidence is lacking that docs prescribe drugs based on their relationships with drug companies. 
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.